Role of Philanthropic Capital in Accelerating India’s Long-Term Scientific R&D
Transformative scientific research requires long-term, risk-tolerant investment before commercially viable outcomes or clear market applications emerge. While governments operate on five-year electoral cycles and corporations focus on quarterly financial reports, foundational scientific breakthroughs often demand decades of sustained support. Philanthropic funding can bridge this gap by backing early-stage discoveries, institution-building, and high-risk research that traditional public and market capital cannot readily support.
What Happened
India currently allocates 0.84 per cent of its gross domestic product (GDP) to research and development (R&D). In comparison, South Korea spends 4.91 per cent, the United States spends 3.48 per cent, and China allocates 2.43 per cent of GDP to R&D. In addition to total expenditure, the composition of funding presents a significant divergence: the private business sector contributes roughly 41 per cent of Indian R&D spending, whereas business accounts for 79 per cent in South Korea, 77 per cent in China, and 75 per cent in the United States.
To accelerate domestic research, the Indian government established the Anusandhan National Research Foundation (ANRF) under the ANRF Act 2023. The initiative aims to build a total corpus of ₹50,000 crore to support early-stage and basic scientific research, with approximately ₹36,000 crore targeted to come from outside government sources, including philanthropic and private capital.
Key Highlights
- India’s R&D expenditure is 0.84 per cent of GDP, with 41 per cent funded by the business sector.
- The ANRF aims to raise approximately ₹36,000 crore of its ₹50,000 crore corpus from non-governmental contributions.
- India currently ranks third globally in the volume of published scientific papers.
- Philanthropic contributions have supported key institutions, such as a ₹100 crore grant by Rohini Nilekani Philanthropies in 2023 to NIMHANS and NCBS for brain research, as well as brain research endowments by Kris Gopalakrishnan at IISc.
- Historical precedents include the founding of the Tata Institute of Fundamental Research (TIFR) in 1945 via a grant from the Sir Dorabji Tata Trust following a proposal by Homi Bhabha, which laid the foundation for India’s atomic energy programme.
Why This Matters
Critical scientific domains—such as genomics, quantum computing, and artificial intelligence—are in formative stages where long-term commitments are essential to establishing national technological independence and resilience. Philanthropic capital is uniquely suited to finance four structural gaps:
- Supporting Existing Public Institutions: Supplying flexible resources to talent-rich research bodies.
- Establishing New Research Entities: Seeding standalone organisations focused on fundamental science.
- Absorbing High Failure Rates: Underwriting high-risk exploration that lenders and commercial investors avoid.
- Addressing Neglected Needs: Developing solutions for populations lacking market purchasing power, such as the development of the affordable MenAfriVac meningitis vaccine manufactured by the Serum Institute of India.
What to Watch Next
Key developments to follow include the mobilisation of the targeted ₹36,000 crore non-governmental capital for the ANRF and the growth of philanthropic contributions directed toward foundational scientific research across emerging deep-tech and medical disciplines.
Frequently Asked Questions
What is India’s current R&D spending relative to GDP?
India allocates 0.84 per cent of its GDP to research and development, compared to 2.43 per cent in China, 3.48 per cent in the US, and 4.91 per cent in South Korea.
What is the funding target for the Anusandhan National Research Foundation (ANRF)?
The ANRF was set up under the ANRF Act 2023 with a target corpus of ₹50,000 crore, of which approximately ₹36,000 crore is intended to be raised from non-governmental sources.
Source: Business Standard